Stockreport

LB Pharmaceuticals Highlights LB-102 Phase 3 Schizophrenia Path, Funding Runway to 2029 at Needham [Yahoo! Finance]

LB Pharmaceuticals Inc  (LBRX) 
PDF to approval in schizophrenia with a single Phase 3, the Phase 3 is underway with topline data expected in the second half of 2027 , and the February PIPE funds the compa [Read more]